Amoebiasis is an infectious disease caused by a single-celled parasite called Entamoeba histolytica that primarily affects the intestine but can spread to the liver and other organs. It continues to represent a significant public health problem worldwide, occurring most frequently in tropical and subtropical regions where access to clean water is limited and sanitation conditions are inadequate. According to World Health Organization data, amoebiasis affects millions of people globally each year and ranks third among parasitic diseases after malaria and sleeping sickness.
The Causative Agent: Entamoeba histolytica
Entamoeba histolytica can exist in two distinct forms within the human intestine. The cyst form is the inactive form that is highly resistant to environmental conditions and is responsible for transmission of the infection. The trophozoite form is the active, motile, and pathogenic form responsible for tissue invasion. It is important to note that species morphologically similar to E. histolytica but incapable of causing disease also exist, including Entamoeba dispar and Entamoeba moshkovskii. This distinction carries considerable clinical and epidemiological importance, as stool microscopy can only detect cysts and cannot differentiate between species.
Routes of Transmission
Amoebiasis is transmitted via the fecal-oral route. Consumption of water or food contaminated with the feces of infected individuals is the most common mode of transmission. Raw vegetables and fruits pose a significant risk factor, particularly when grown on agricultural land fertilized with human feces. Food handlers who neglect hand hygiene also play a critical role in the chain of transmission. Crowded living conditions, institutional care settings, and certain sexual practices are additional factors that increase the risk of transmission.
Clinical Forms of the Disease
Amoebiasis presents an extremely wide clinical spectrum. Approximately ninety percent of infected individuals are asymptomatic carriers who continue to shed cysts without showing any signs of illness, thereby contributing to transmission within the community.
Intestinal Amoebiasis
Symptomatic intestinal disease arises when parasite trophozoites invade the colonic mucosa. Mild cases may present with abdominal pain, cramping, and soft or watery stools. The classic picture of amoebic dysentery is characterized by frequent passage of stools containing blood and mucus accompanied by tenesmus. Fever is relatively uncommon but may appear in severe cases. Intestinal perforation and peritonitis are rare but life-threatening complications. Amoeboma is a granulomatous reaction that can develop in the large intestine in chronic infection, forming a mass-like lesion that may be confused with colorectal cancer.
Extraintestinal Amoebiasis
Trophozoites can reach organs outside the intestine via the portal circulation. The most frequently encountered and most important extraintestinal form is amoebic liver abscess.
Amoebic liver abscess is the most common extraintestinal complication of amoebiasis. It typically presents as a single abscess in the right lobe of the liver. The clinical picture consists of right upper quadrant pain, fever, malaise, and weight loss. Intestinal symptoms may not be present concurrently; indeed, no evidence of active intestinal infection may be detectable. If left untreated, the abscess can rupture into the pleural cavity, the peritoneal space, or the pericardium.
Less common extraintestinal forms include pulmonary amoebiasis, cerebral abscess, and cutaneous amoebiasis.
Diagnostic Methods
The diagnosis of amoebiasis requires the use of multiple methods in combination. Microscopic examination of stool has historically been the primary diagnostic method; however, its sensitivity is low and it does not always allow E. histolytica to be distinguished from other amoeba species. Stool antigen detection involves immunological tests that identify E. histolytica-specific antigens and is superior to microscopy in terms of both specificity and sensitivity. PCR-based methods currently offer the highest sensitivity and specificity of any diagnostic tool and can definitively differentiate between species. Serological tests are particularly valuable in the diagnosis of extraintestinal amoebiasis; antibodies are detected at high levels in invasive disease. In cases of suspected liver abscess, ultrasonography and CT imaging are used to establish the presence, location, and dimensions of the abscess.
Treatment
The treatment of amoebiasis is tailored to the clinical form of the disease.
In asymptomatic carriage, luminal amoebicides such as paromomycin or diloxanide furoate are preferred. These agents act against cysts and trophozoites within the intestinal lumen.
For symptomatic intestinal amoebiasis and extraintestinal forms, nitroimidazole-class agents such as metronidazole or tinidazole constitute the cornerstone of treatment. These drugs act against tissue trophozoites but may not completely eradicate parasites within the intestinal lumen. For this reason, completion of treatment with a luminal amoebicide following systemic therapy is recommended.
In amoebic liver abscess, pharmacological treatment is usually sufficient. Percutaneous aspiration or drainage may be performed in large abscesses, in situations where the risk of rupture is high, or when an adequate response to drug therapy cannot be achieved.
Prevention and Control
The foundation of protection against amoebiasis lies in improving hygiene and sanitation conditions. Purification and boiling of drinking water, thorough washing of raw vegetables and fruits with clean water, attention to hand hygiene, and adherence to food safety principles are the most effective preventive measures available at the individual level. Persons traveling to endemic regions should pay particular attention to these precautions. No approved and effective vaccine against amoebiasis currently exists, and research in this area continues.
Conclusion
Amoebiasis remains a parasitic disease of global significance. Its broad clinical spectrum, ranging from asymptomatic carriage to life-threatening liver abscess, complicates diagnosis and necessitates maintaining a high index of suspicion. Early diagnosis is of critical importance given the availability of effective pharmacological treatment. However, the long-term solution lies not only in individual preventive measures but also in the improvement of clean water infrastructure and sanitation conditions at the community level.